BackPhreesia Overview
Phreesia Inc

Phreesia Target Price

Analysts' average 12-month price target for Phreesia is $12.

Get informed when a big investor buys or sells

+ Follow

Share Price

$12.26

Average Target Price

$12.170.8% downside

6 analysts in the last 4 months

High: $16 | Low: $9

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-05-28Piper SandlerJessica Tassan$122.1% downsideOpen
2026-05-28D.A. DavidsonClark Wright$1414.2% upsideOpen
2026-05-28Truist FinancialJailendra Singh$122.1% downsideOpen
2026-05-28Canaccord Genuity$1630.5% upsideOpen
2026-05-20Wells FargoStan Berenshteyn$926.6% downsideOpen
2026-05-14Barclays$1018.4% downsideOpen
2026-02-04Mizuho SecuritiesSteven Valiquette$2279.4% upsideOpen
2026-01-23D.A. Davidson$30144.7% upsideOpen
2026-01-08Wells FargoStan Berenshteyn$30144.7% upsideOpen
2026-01-08Truist Financial$2495.8% upsideOpen
2025-12-16Barclays$2495.8% upsideOpen
2025-12-10Truist Financial$29136.5% upsideOpen
2025-12-10Mizuho SecuritiesSteven Valiquette$28128.4% upsideOpen
2025-12-10Robert W. Baird$25103.9% upsideOpen
2025-12-09Canaccord GenuityRichard Close$33169.2% upsideOpen
2025-12-08Barclays$26112.1% upsideOpen
2025-12-02D.A. DavidsonClark Wright$35185.5% upsideOpen
2025-10-08KeyBanc$32161% upsideOpen
2025-09-08JMP SecuritiesAaron Kimson$34177.3% upsideOpen
2025-09-05Truist Financial$36193.6% upsideOpen
2025-09-05Raymond James$33169.2% upsideOpen
2025-09-05D.A. Davidson$33169.2% upsideOpen
2025-09-05Canaccord GenuityRichard Close$38210% upsideOpen
2024-12-11Robert W. BairdJoe Vruwink$30144.7% upsideOpen
2024-11-29D.A. DavidsonGil Luria$32161% upsideOpen
2024-09-06Truist FinancialJailendra Singh$31152.9% upsideOpen
2024-09-06Robert W. BairdJoe Vruwink$34177.3% upsideOpen
2024-09-05Piper SandlerSean Wieland$30144.7% upsideOpen
2024-05-31Canaccord GenuityRichard Close$34177.3% upsideOpen
2024-05-29Truist FinancialJailendra Singh$35185.5% upsideOpen
2024-05-24KeyBancScott Schoenhaus$30144.7% upsideOpen
2024-03-21JMP SecuritiesAaron Kimson$30144.7% upsideOpen
2024-03-18Robert W. BairdJoe Vruwink$31152.9% upsideOpen
2024-03-15RBC CapitalSean Dodge$2387.6% upsideOpen
2023-12-06NeedhamRyan MacDonald$29136.5% upsideOpen
2023-09-07StephensJeff Garro$37201.8% upsideOpen
2023-01-04NeedhamRyan MacDonald$40226.3% upsideOpen
2022-12-09RBC Capital$26112.1% upsideOpen
2022-10-12D.A. DavidsonRobert Simmons$25103.9% upsideOpen
2022-03-30Robert W. BairdJoseph Vruwink$51316% upsideOpen
2022-03-30Leerink PartnersStephanie Davis$29136.5% upsideOpen
2021-09-02Cantor FitzgeraldSteven Halper$70471% upsideOpen
2021-07-12KeyBancDonald Hooker$73495.4% upsideOpen
2021-06-08Berenberg BankGal Munda$70471% upsideOpen

Phreesia (PHR) FAQ

Phreesia (PHR) currently reports a target price of $12. Use the charts on this page to explore Phreesia's target price history and peer comparisons.

Analysts' average 12-month price target for Phreesia is $12, about 0.8% downside from the current share price of $12.26. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $12, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Phreesia, and consider following PHR for alerts when major investors trade the stock.

Phreesia is classified in the Healthcare sector. On target price, it currently shows $12. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing PHR with unrelated industries.